A bimodal model of the mechanism of action of lithium

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Investigations of the biochemical actions of lithium have identified many individual reactions that are affected, especially within cellular signaling systems, but the actions of lithium at different sites often appear opposing and difficult to integrate into a general mechanism of action. A bimodal mechanism of action of lithium is proposed which is in accord with many of the apparently contradictory results that have been published. This model describes the critical effect of lithium as that of a stabilizer of the magnitude of fluctuations of signaling processes. This is achieved by lithium balancing positive and negative regulators of signaling processes which results in lithium raising basal activities and diminishing maximal activities, thereby stabilizing signaling activities within an optimal range and preventing fluctuations either above or below this optimum. This model is shown to be applicable to many published results concerning the activation of AP-1 DNA binding and cyclic AMP production. Diverse sites of action of lithium are proposed to ultimately converge on the regulation of gene expression to contribute to mood stabilization.

Original languageEnglish
Pages (from-to)21-25
Number of pages5
JournalMolecular Psychiatry
Volume4
Issue number1
StatePublished - Feb 2 1999
Externally publishedYes

Fingerprint

Lithium
Transcription Factor AP-1
Gene Expression Regulation
Cyclic AMP
DNA

Keywords

  • AP-1
  • Bipolar disorder
  • Carbamazepine
  • Cyclic AMP
  • Lithium
  • Valproate

ASJC Scopus subject areas

  • Molecular Biology
  • Psychiatry and Mental health

Cite this

A bimodal model of the mechanism of action of lithium. / Jope, Richard S.

In: Molecular Psychiatry, Vol. 4, No. 1, 02.02.1999, p. 21-25.

Research output: Contribution to journalArticle

@article{7abe1667857541c3b7e676747ad6e63b,
title = "A bimodal model of the mechanism of action of lithium",
abstract = "Investigations of the biochemical actions of lithium have identified many individual reactions that are affected, especially within cellular signaling systems, but the actions of lithium at different sites often appear opposing and difficult to integrate into a general mechanism of action. A bimodal mechanism of action of lithium is proposed which is in accord with many of the apparently contradictory results that have been published. This model describes the critical effect of lithium as that of a stabilizer of the magnitude of fluctuations of signaling processes. This is achieved by lithium balancing positive and negative regulators of signaling processes which results in lithium raising basal activities and diminishing maximal activities, thereby stabilizing signaling activities within an optimal range and preventing fluctuations either above or below this optimum. This model is shown to be applicable to many published results concerning the activation of AP-1 DNA binding and cyclic AMP production. Diverse sites of action of lithium are proposed to ultimately converge on the regulation of gene expression to contribute to mood stabilization.",
keywords = "AP-1, Bipolar disorder, Carbamazepine, Cyclic AMP, Lithium, Valproate",
author = "Jope, {Richard S}",
year = "1999",
month = "2",
day = "2",
language = "English",
volume = "4",
pages = "21--25",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - A bimodal model of the mechanism of action of lithium

AU - Jope, Richard S

PY - 1999/2/2

Y1 - 1999/2/2

N2 - Investigations of the biochemical actions of lithium have identified many individual reactions that are affected, especially within cellular signaling systems, but the actions of lithium at different sites often appear opposing and difficult to integrate into a general mechanism of action. A bimodal mechanism of action of lithium is proposed which is in accord with many of the apparently contradictory results that have been published. This model describes the critical effect of lithium as that of a stabilizer of the magnitude of fluctuations of signaling processes. This is achieved by lithium balancing positive and negative regulators of signaling processes which results in lithium raising basal activities and diminishing maximal activities, thereby stabilizing signaling activities within an optimal range and preventing fluctuations either above or below this optimum. This model is shown to be applicable to many published results concerning the activation of AP-1 DNA binding and cyclic AMP production. Diverse sites of action of lithium are proposed to ultimately converge on the regulation of gene expression to contribute to mood stabilization.

AB - Investigations of the biochemical actions of lithium have identified many individual reactions that are affected, especially within cellular signaling systems, but the actions of lithium at different sites often appear opposing and difficult to integrate into a general mechanism of action. A bimodal mechanism of action of lithium is proposed which is in accord with many of the apparently contradictory results that have been published. This model describes the critical effect of lithium as that of a stabilizer of the magnitude of fluctuations of signaling processes. This is achieved by lithium balancing positive and negative regulators of signaling processes which results in lithium raising basal activities and diminishing maximal activities, thereby stabilizing signaling activities within an optimal range and preventing fluctuations either above or below this optimum. This model is shown to be applicable to many published results concerning the activation of AP-1 DNA binding and cyclic AMP production. Diverse sites of action of lithium are proposed to ultimately converge on the regulation of gene expression to contribute to mood stabilization.

KW - AP-1

KW - Bipolar disorder

KW - Carbamazepine

KW - Cyclic AMP

KW - Lithium

KW - Valproate

UR - http://www.scopus.com/inward/record.url?scp=0033013011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033013011&partnerID=8YFLogxK

M3 - Article

C2 - 10089004

AN - SCOPUS:0033013011

VL - 4

SP - 21

EP - 25

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 1

ER -